Interestingly, conjugation of another IL-13Rα2 mAb to auristatin did not impact growth of certain IL-13Rα2-expressing diffuse intrinsic pontine glioma (DIPG) cell lines (94), suggesting selection of appropriate drug conjugates is critical for efficacy in different tumor settings. This evidence concerns the gene IL13RA2 and neoplasm.